scholarly journals Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets

2019 ◽  
Vol 8 (S1) ◽  
pp. S1-S1 ◽  
Author(s):  
Gianluca Spitaleri ◽  
Antonio Passaro ◽  
Filippo de Marinis
Sign in / Sign up

Export Citation Format

Share Document